Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.

NCT04422444 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT04422444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04422444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization and Management of Post Intensive Care Syndrome in COVID19 Patients.
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
June 1, 2020
Completion date
June 1, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, post intensive care unit syndrome